Cardinal Health Raises FY26 EPS Outlook to at Least $10.00, Highlights Strategic Growth
CAH sits 71% above its 52-week low of $119.25.
Summary
Cardinal Health increased its fiscal year 2026 non-GAAP EPS guidance and reported strong progress in specialty growth and strategic initiatives, including a new partnership with Publix.
Key Events · Earnings and Guidance · CAH
-
Raised Fiscal 2026 EPS Outlook
Increased non-GAAP diluted EPS guidance to "at least $10.00" from the previous range of $9.65 to $9.85, signaling strong performance.
-
Accelerating Specialty Growth
Expects Specialty revenues to exceed $50 billion in fiscal 2026, representing a 16% compounded annual growth rate over three years, driven by robust demand and BioPharma Solutions growth.
-
Successful IRA Transition
Confirmed successful transition of manufacturer distribution service agreements for all branded pharmaceutical products impacted by the 2026 Medicare Drug Price Negotiation Program.
-
New ContinuCare™ Pathway Program
Launched an innovative direct-to-patient program to simplify diabetes supply management, securing a key partnership with Publix Super Markets Inc. for nearly 1,400 pharmacies.
Analysis · CAH · Trade & Services
Cardinal Health's updated fiscal year 2026 non-GAAP EPS outlook, now "at least $10.00" from a prior range of $9.65 to $9.85, signals strong operational performance and management confidence. This positive revision, coupled with significant strategic progress in specialty growth, successful navigation of IRA changes, and the launch of a new diabetes supply management program with a major partner like Publix, indicates robust business momentum. Investors should view this as a positive indicator of the company's ability to execute its growth strategy and manage regulatory changes effectively.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 29.9% of the 1939 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAH was trading at $203.54 on NYSE in the Trade & Services sector, with a market capitalization of approximately $48.1B. The 52-week trading range was $119.25 to $214.93. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.